Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20130812014333N165Phase 3Completed
Phase 3, randomised, double-blind trial in ureterolithiasis comparing Intrathecal Marcaine with Intrathecal pethidine (2 arms). Primary endpoints: Changes in blood pressure, Changes in heart rate and 1 more. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20130812014333N165.